Literature DB >> 28971447

Huntington Disease: Genetics, Prevention, and Therapy Approaches.

Christos Yapijakis1,2,3.   

Abstract

Huntington's chorea or Huntington disease (HD) is a late-onset autosomal dominant neurodegenerative disorder caused by a trinucleotide repeat expansion. The multidisciplinary study of HD has been the focus of an international collaborating effort of basic and applied research for several decades. HD was the first human genetic disease mapped using linkage analysis of DNA polymorphisms and became a paradigm for scores of genes mapped in the same manner. Presymptomatic and prenatal testing have been available for HD families in the last 30 years, following genetic counseling and careful bioethical guidelines. Nevertheless, with the cure for the disease still elusive the uptake of predictive testing by at risk individuals is low. Current treatment of HD is mostly symptomatic, but ongoing observational studies, clinical trials and development of new gene silencing technologies have provided hopeful results.

Entities:  

Keywords:  Hereditary chorea; Late-onset disorder; Neurodegenerative disease; Prenatal testing; presymptomatic testing

Mesh:

Substances:

Year:  2017        PMID: 28971447     DOI: 10.1007/978-3-319-57379-3_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).

Authors:  Shradha Mukherjee
Journal:  Heliyon       Date:  2021-12-01

2.  Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles.

Authors:  Viktor Dombrádi; Erica Pitini; Carla G van El; Anant Jani; Martina Cornel; Paolo Villari; Muir Gray; Klára Bíró
Journal:  BMC Health Serv Res       Date:  2019-11-11       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.